15 results
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
13 Sep 23
Report of Foreign Private Issuer
4:03pm
Goals with Patients 2018. National Know Narcolepsy Survey. https://knownarcolepsy.com/hcp/impact DEMOGRAPHICS Majority of patients are female (64
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
30 Aug 23
Report of Foreign Private Issuer
5:25pm
made towards achieving both our short and our long-term goals.
At the outset of 2023, we outlined a number of objectives including:
Continuing
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
20 Jul 23
Report of Foreign Private Issuer
4:06pm
: Aligning Treatment Goals with Patients 2018. National Know Narcolepsy Survey. https://knownarcolepsy.com/hcp/impact Misdiagnosis is reported in more
6-K
EX-99.2
NLSP
NLS Pharmaceutics Ltd
3 Jul 23
NLS Pharmaceutics Releases the Results from its Annual General Meeting
1:22pm
:
Feedback from the SLEEP 2023 APSS Conference
Initiation of the Phase 3 program AMAZE for Mazindol ER
Pipeline Goals for 2023/2024
Key Financials
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
22 Dec 22
NLS Pharmaceutics CEO Issues Letter to Shareholders
9:40am
. As we look towards 2023 and beyond, we know that we have a strong and proficient team in place to meet and exceed our goals.
Expanding our Pipeline
6-K
EX-99.1
iqttp8fkii17
1 Nov 21
NLS Pharmaceutics CEO Issues Letter to Shareholders
8:18am
424B4
qh58ze44hzd7gqq
1 Feb 21
Prospectus supplement with pricing info
11:52am
F-1/A
ajuewa4l261x1i aaj
20 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
3dln 8wgofiix1yz
17 Nov 20
Registration statement (foreign) (amended)
5:28pm
F-1/A
hvp42v 82l1xdtaa
16 Oct 20
Registration statement (foreign) (amended)
9:59pm
F-1/A
6x4vwpb8sn9kgj
31 Aug 20
Registration statement (foreign) (amended)
9:26am
F-1
h3e247a
28 Feb 20
Registration statement (foreign)
5:37pm
F-1
EX-10.16
t8mkow9t221
28 Feb 20
Registration statement (foreign)
5:37pm
DRS/A
asv8so ah3
20 Feb 20
Draft registration statement (amended)
12:00am
DRS
qmwb uuuxi7cudvja
18 Dec 19
Draft registration statement
12:00am
- Prev
- 1
- Next